MiR-221 and miR-222 simultaneously target ARID1A and enhance proliferation and invasion of cervical cancer cells.

OBJECTIVE To explore the expression level of neuron-specific enolase (NSE), S100B and neuropeptide Y (NPY) in children with acute miliary tuberculosis and secondary tubercular meningitis. PATIENTS AND METHODS 28 children diagnosed with acute miliary tuberculosis and secondary tubercular meningitis were included into group A, 25 children diagnosed with pure acute miliary tuberculosis were included into group B and 23 children diagnosed with suspected meningitis were included into group C. The levels of NSE, S100B and NPY in cerebrospinal fluid and serum were detected. RESULTS The levels of NSE, S100B and NPY in cerebrospinal fluid and serum of group A were significantly higher than the levels in the other two groups, differences were statistically significant (p<0.05). A multifactor retrospective analysis suggested that secondary tubercular meningitis was significantly correlated with the high expression of S100B, NPY and NSE in cerebrospinal fluid and serum. CONCLUSIONS Early detection of the expression levels of NSE, S100B and NPY in cerebrospinal fluid and serum was of great value for the diagnosis of tubercular meningitis secondary to acute miliary tuberculosis.

[1]  M. Tommasino,et al.  The biological properties of E6 and E7 oncoproteins from human papillomaviruses , 2010, Virus Genes.

[2]  D. Aoki,et al.  MicroRNA in Cervical Cancer: OncomiRs and Tumor Suppressor miRs in Diagnosis and Treatment , 2014, TheScientificWorldJournal.

[3]  Shikai Liu,et al.  miR-21 modulates resistance of HR-HPV positive cervical cancer cells to radiation through targeting LATS1. , 2015, Biochemical and biophysical research communications.

[4]  M. Benczik,et al.  Unique microRNA expression profiles in cervical cancer. , 2013, Anticancer research.

[5]  L. Fan,et al.  High MALAT1 expression predicts a poor prognosis of cervical cancer and promotes cancer cell growth and invasion. , 2015, European review for medical and pharmacological sciences.

[6]  A. Jemal,et al.  Cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.

[7]  S. Zanetti,et al.  HPV infection in HIV-positive females: the need for cervical cancer screening including HPV-DNA detection despite successful HAART. , 2014, European review for medical and pharmacological sciences.

[8]  F. Qiu,et al.  DNA damage regulates ARID1A stability via SCF ubiquitin ligase in gastric cancer cells. , 2015, European review for medical and pharmacological sciences.

[9]  Xiaomei Wang,et al.  Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell‐cycle control , 2007, The EMBO journal.

[10]  J. Liu,et al.  Reduced expression of miR-503 is associated with poor prognosis in cervical cancer. , 2015, European review for medical and pharmacological sciences.

[11]  L. L,et al.  Different Expression of p 16 INK 4 a and p 14 ARF in cervical and lung cancers , 2013 .

[12]  Elizabeth E. Hoskins,et al.  Alteration of microRNA profiles in squamous cell carcinoma of the head and neck cell lines by human papillomavirus , 2011, Head & neck.

[13]  J. Li,et al.  miR-506 acts as a tumor suppressor by directly targeting the hedgehog pathway transcription factor Gli3 in human cervical cancer , 2014, Oncogene.

[14]  Hui Li,et al.  MiR-31 is an independent prognostic factor and functions as an oncomir in cervical cancer via targeting ARID1A. , 2014, Gynecologic oncology.

[15]  Tian-Li Wang,et al.  ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers. , 2011, Cancer research.

[16]  Yu Li,et al.  Genomic and functional evidence for an ARID1A tumor suppressor role , 2007, Genes, chromosomes & cancer.

[17]  Yuanbo Li,et al.  MicroRNA-221 targets PTEN to reduce the sensitivity of cervical cancer cells to gefitinib through the PI3K/Akt signaling pathway , 2016, Tumor Biology.

[18]  Ping Liu,et al.  Mir-155 promotes cervical cancer cell proliferation through suppression of its target gene LKB1 , 2014, Tumor Biology.

[19]  C. Woodman,et al.  The natural history of cervical HPV infection: unresolved issues , 2007, Nature Reviews Cancer.

[20]  Yi Sun,et al.  MicroRNA-222 promotes the proliferation and migration of cervical cancer cells. , 2014, Clinical and investigative medicine. Medecine clinique et experimentale.

[21]  H. Katagiri,et al.  Frequent Loss of Tumor Suppressor ARID1A Protein Expression in Adenocarcinomas/Adenosquamous Carcinomas of the Uterine Cervix , 2011, International Journal of Gynecologic Cancer.